Mirador Global is a consulting firm providing drug commercialization assessment and launch planning services in Oncology, Immuno-Oncology, Orphan and CNS/Pain/Addiction for small and medium-sized bio-pharma companies around the world. We work in these disease areas for two key reasons – professional therapeutic experience and personal passion. Our distinctive line of sight comes from the vantage point of our founders and our team having previously sat in the seats of our clients for decades. Our experts have spent much of their careers honing skills unique to bio-pharma such as Strategic Planning, Marketing, Market Access, Pricing, Medical Affairs, and Analytics.

Each one of our client engagements is developed using Mirador Global’s proprietary Integration Methodology – addressing the single most significant gap in successfully creating and executing product launches. Bringing together Marketing, Medical Affairs, R&D and other functions in candid and constructive ways only possible with industry experts is what elevates our work to exceptional levels. We also offer clients the option of using our specialists for selective support to their commercial teams or to be their initial commercial teams before they are ready to internally hire.

What We Do: 
• Global Commercial Strategy Development
• ​US & Global Forecasting and Asset Valuation
• Payer Reimbursement Risk Assessment & Mitigation
• Portfolio Assessment and Prioritization
• Commercial Road Map and Launch Planning



Biotechnology

Life Sciences

Pharmaceutical

Therapeutics

Mirador Global LLC

Chuck Peipher

Kaylor Kowash

Tom Ross

Lizzie Grosset

Karin Turturro - Iuzzini

Fusun Sevgen

Bindul Turakhia

Mirador Global LLC

Org chart

Similar companies